MarketCapExport financials
American Shared Hospital Services (AMS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
American Shared Hospital Services Financial Ratios 2025-2008 | AMS
Brief overview of American Shared Hospital Services's market valuation
This overview follows the five latest available observations from 2019 through 2024.
The valuation comparison uses P/E 8.92x (median 23.26x), EV/EBITDA 15.95x (median 4.94x), P/S 0.34x (median 0.81x). Valuation is roughly 46.6% below five-year reference levels. The discount may reflect opportunity or higher perceived risk.
The inverse P/E implies an earnings yield of 11.2%. This is not a dividend yield, but current earnings relative to market price.
End-period return metrics are ROE -6.5%, ROA -2.8%, ROCE -14.9%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.
A longer cycle, from 71.4 days to 126.6 days, indicates slower release of cash from operations.
Valuation takeaway
American Shared Hospital Services's multiples look low against history, but fundamental returns do not yet provide convincing support.
Annual Financial Ratios American Shared Hospital Services
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.2 | 8.9 | 30.5 | 13.6 | 73.8 | - | 23.3 | 14.3 | 8.1 | 26.5 | -5.5 | -13.1 | -40.7 | 270.5 | 25.9 | 217.7 | - | - | |
P/S |
0.3 | 0.7 | 0.9 | 0.9 | 0.8 | 58.0 | 0.7 | 0.7 | 0.8 | 1.3 | 0.5 | 0.8 | 0.7 | 0.6 | 0.6 | - | - | - |
EPS |
-0.2 | 0.3 | 0.1 | 0.2 | 0.0 | -1.1 | 0.1 | 0.2 | 0.3 | 0.2 | -0.3 | -0.2 | -0.1 | 0.0 | 0.1 | 0.0 | -0.0 | - |
EV (Enterprise Value) |
33.9 M | 38.6 M | 26.8 M | 24.1 M | 27.4 M | 31.3 M | 35.9 M | 39.6 M | 41.8 M | 55.2 M | 35 M | 52.8 M | 58.5 M | 57.2 M | 62.4 M | 12.4 M | - | - |
EBITDA per Share |
0.32 | 0.52 | 0.85 | 1.15 | 1.05 | 0.00115 | 1.74 | 1.81 | 1.89 | 2.07 | 1.73 | 1.6 | 2.09 | 1.95 | 2.22 | 1.49 | - | - |
EV/EBITDA |
16.0 | 11.5 | 4.9 | 3.3 | 0.6 | 1828.5 | 1.7 | 1.8 | 1.8 | 2.6 | 1.7 | 3.8 | 3.8 | 3.9 | 2.5 | 1.8 | - | - |
PEG |
-0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -0.61 | -0.31 | 0.09 | 0.16 | 0.12 | 0.08 | 0.04 | -2.92 | 0.03 | - | - | - |
P/B |
0.3 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.9 | 0.3 | 0.5 | 0.5 | 0.4 | 0.5 | 0.2 | - | - |
P/CF |
3.1 | 116.7 | 3.3 | 2.5 | 2.3 | 1.6 | 2.2 | 2.3 | 2.2 | 3.6 | 1.3 | 8.0 | 2.0 | 43.4 | 10.8 | 1.7 | - | - |
ROE % |
-6.46 | 8.68 | 2.70 | 6.14 | 0.98 | - | 2.07 | 3.29 | 6.43 | 3.42 | -6.04 | -3.64 | -1.30 | 0.15 | 2.01 | 0.29 | -0.83 | - |
ROA % |
-2.80 | 3.63 | 1.27 | 3.02 | 0.43 | - | 1.23 | 1.78 | 3.31 | 1.53 | -2.81 | -1.41 | -0.43 | 0.05 | 0.68 | 0.09 | - | - |
ROCE % |
-14.93 | -11.14 | 1.19 | 11.24 | 6.79 | - | 6.28 | 7.27 | 8.83 | 9.62 | 7.09 | 3.22 | 4.87 | 4.53 | 6.12 | 4.42 | 2.87 | - |
Current Ratio |
2.0 | 2.0 | 2.2 | 2.4 | 2.1 | 0.9 | 1.3 | 1.0 | 1.0 | 1.0 | 0.7 | 0.9 | 0.7 | 1.7 | 1.8 | - | - | - |
DSO |
143.8 | 102.7 | 69.7 | 74.0 | 88.1 | 5971.8 | 125.1 | 127.3 | 97.7 | 85.4 | 69.4 | 78.7 | 96.8 | 87.9 | 78.2 | - | - | - |
DPO |
17.2 | 17.9 | 8.3 | 8.8 | 16.8 | - | 14.9 | 13.0 | 12.0 | 11.8 | 13.9 | 15.2 | 19.6 | 9.5 | 7.1 | 6.5 | - | - |
Operating Cycle |
143.8 | 102.7 | 69.7 | 74.0 | 88.1 | - | 125.1 | 127.3 | 97.7 | 85.4 | 69.4 | 78.7 | 96.8 | 87.9 | 78.2 | - | - | - |
Cash Conversion Cycle |
126.6 | 84.8 | 61.4 | 65.2 | 71.4 | - | 110.3 | 114.4 | 85.7 | 73.6 | 55.4 | 63.5 | 77.2 | 78.4 | 71.1 | -6.5 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios American Shared Hospital Services
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.04 | -0.09 | - | - | -0.04 | -0.1 | - | -0.03 | 0.56 | 0.02 | - | 0.02 | -0.02 | 0.03 | - | 0.05 | 0.08 | 0.04 | - | 0.01 | -0.01 | - | - | -0.03 | -0.08 | -0.02 | - | 0.03 | 0.08 | 0.05 | - | 0.03 | 0.05 | 0.07 | - | 0.02 | 0.02 | 0.05 | - | 0.06 | 0.02 | 0.01 | - | 0.01 | -0.36 | 0.02 | - | - | -0.2 | -0.02 | - | -0.03 | -0.03 | 0.01 | - | - | - | - | - | 0.05 | - | - |
EBITDA per Share |
0.15 | 0.06 | - | 0.17 | 0.15 | 0.02 | - | 0.12 | 0.23 | 0.19 | - | 0.21 | 0.15 | 0.23 | - | 0.26 | 0.32 | 0.29 | - | 0.64 | 0.49 | 0.21 | - | 0.82 | 0.46 | 0.26 | - | 0.38 | 1.19 | 0.41 | - | 0.91 | 0.69 | 0.42 | - | 0.92 | 0.68 | 0.42 | - | 1.05 | 0.66 | 0.37 | - | 0.91 | 0.66 | 0.36 | - | 0.97 | 0.57 | 0.34 | - | 1.06 | 0.74 | 0.41 | - | 1.04 | 0.7 | 0.39 | - | 1.15 | 0.67 | 0.36 |
ROE % |
-6.85 | -6.35 | -3.75 | -4.40 | 6.80 | 8.40 | 10.93 | 11.39 | 11.61 | 1.20 | 0.75 | 1.99 | 3.50 | 5.53 | 4.80 | 4.94 | 3.58 | 1.98 | 0.39 | -0.70 | -3.34 | -3.93 | -4.29 | -3.65 | -0.78 | 2.77 | 3.47 | 4.14 | 4.64 | 4.40 | 3.37 | 3.78 | 3.59 | 3.67 | 2.12 | 3.67 | 3.69 | 3.45 | 2.22 | 2.44 | -8.90 | -8.70 | -8.94 | -8.88 | -13.42 | -4.08 | -4.71 | -5.40 | -6.08 | -1.63 | -1.18 | -1.13 | -0.37 | 0.29 | 0.17 | 1.25 | 1.31 | 1.34 | 1.30 | 1.09 | 0.10 | 0.10 |
ROA % |
-3.23 | -2.58 | -1.46 | -1.78 | 4.17 | 4.84 | 5.83 | 6.08 | 6.16 | 0.67 | 0.43 | 1.16 | 2.03 | 3.17 | 2.73 | 2.81 | 2.02 | 1.10 | 0.21 | -0.27 | -1.45 | -1.70 | -1.89 | -1.60 | -0.25 | 1.36 | 1.67 | 1.96 | 2.16 | 1.97 | 1.47 | 1.64 | 1.54 | 1.55 | 0.87 | 1.42 | 1.40 | 1.29 | 0.79 | 0.87 | -3.32 | -3.24 | -3.32 | -3.30 | -4.76 | -1.26 | -1.50 | -1.68 | -1.87 | -0.46 | -0.32 | -0.31 | -0.10 | 0.08 | 0.05 | 0.34 | 0.36 | 0.36 | 0.35 | 0.30 | 0.03 | 0.03 |
ROCE % |
-9.36 | -12.82 | -8.89 | -11.69 | -10.29 | -8.39 | -3.12 | -2.77 | -1.24 | -0.86 | -0.54 | 1.22 | 4.01 | 7.70 | 7.32 | 8.10 | 7.82 | 5.07 | 2.64 | 1.34 | -2.40 | -4.40 | -4.77 | -3.04 | 3.11 | 8.05 | 8.56 | 9.30 | 10.13 | 8.44 | 6.47 | 8.31 | 10.37 | 10.97 | 7.81 | 11.97 | 12.19 | 11.71 | 8.55 | 10.12 | 8.32 | 8.53 | 6.20 | 7.48 | 3.11 | 0.25 | -2.01 | -1.19 | -1.02 | 3.89 | 4.37 | 5.43 | 5.73 | 5.48 | 3.38 | 7.41 | 7.47 | 7.46 | 6.26 | 4.02 | 1.11 | 1.12 |
Current Ratio |
2.0 | 1.9 | 2.0 | 1.9 | 1.8 | 1.9 | 2.0 | 2.0 | 2.1 | 2.1 | 2.2 | 2.2 | 2.4 | 2.5 | 2.4 | 2.4 | 2.3 | - | 2.1 | - | 2.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.3 | 3.5 | 4.0 | 1.8 | 1.6 | 2.9 | 2.9 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | - | - | - | - |
DSO |
136.1 | 142.8 | - | 136.0 | 118.2 | 151.9 | - | 112.4 | 97.2 | 94.2 | - | 77.1 | 74.2 | 75.7 | - | 65.3 | 73.8 | 84.6 | - | 92.7 | 91.8 | 95.1 | - | 84.1 | 98.4 | 111.8 | - | 115.4 | 39.8 | 106.3 | - | 112.3 | 97.1 | 90.5 | - | 99.3 | 92.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
14.2 | 20.8 | - | 15.6 | 17.1 | 24.6 | - | 21.4 | 11.2 | 8.6 | - | 9.7 | 8.2 | 7.3 | - | 6.6 | 8.4 | 11.7 | - | 10.3 | 19.1 | 24.4 | - | 17.6 | 20.2 | - | - | 21.6 | 14.7 | 13.4 | - | 14.0 | 12.8 | 11.7 | - | 12.0 | 12.2 | 12.1 | - | 11.7 | 10.9 | 12.6 | - | 14.1 | 13.2 | 14.4 | - | 16.1 | 15.2 | 16.3 | - | 18.5 | 19.4 | 14.9 | - | 9.4 | 9.9 | 9.6 | - | 3.8 | 10.7 | - |
Operating Cycle |
- | - | - | 136.0 | 118.2 | 151.9 | - | 112.4 | 97.2 | 94.2 | - | 77.1 | 74.2 | 75.7 | - | 65.3 | 73.8 | 84.6 | - | 92.7 | 91.8 | 95.1 | - | 84.1 | 98.4 | 111.8 | - | 115.4 | 39.8 | 106.3 | - | 112.3 | 97.1 | 90.5 | - | 99.3 | 92.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 120.4 | 101.1 | 127.2 | - | 91.0 | 86.0 | 85.6 | - | 67.4 | 66.0 | 68.4 | - | 58.7 | 65.4 | 72.9 | - | 82.4 | 72.6 | 70.7 | - | 66.4 | 78.2 | 111.8 | - | 93.7 | 25.1 | 92.9 | - | 98.3 | 84.3 | 78.8 | - | 87.3 | 80.5 | -12.1 | - | -11.7 | -10.9 | -12.6 | - | -14.1 | -13.2 | -14.4 | - | -16.1 | -15.2 | -16.3 | - | -18.5 | -19.4 | -14.9 | - | -9.4 | -9.9 | -9.6 | - | -3.8 | -10.7 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company American Shared Hospital Services, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Russia
Germany
Britain
China
